Xinhua Silk Road: Guotai Haitong Securities Holds Biopharma and AI Conference in Shanghai, East China
Conference Overview: The 2025 Shanghai pioneering industries conference, hosted by Guotai Haitong Securities, gathered nearly 100 industry leaders and around 1,000 investors to discuss trends in biopharmaceuticals and technology, featuring the 14th pharmaceutical CEO forum and the 5th AI conference.
Key Discussions: Topics included innovative drug research, medical technology advancements, globalization of pharmaceutical firms, and AI applications, with senior executives from 50 leading pharmaceutical companies sharing insights during approximately 10 roundtables.
AI and Technology Focus: The technology segment highlighted AI's disruptive impact, discussing hardware innovations like AI chips and intelligent computing centers, as well as software applications in gaming, video content generation, and health management.
Future Commitment: Guotai Haitong Securities emphasized its commitment to supporting the high-quality development of pioneering industries by leveraging its expertise and resources to track industry trends and investment opportunities.
About the author









